Here we showed that C5a protected human CD4+ T cells from undergoing apoptosis and C5a promoted IL-22 and IL-17 expression from CD4+ T cells of AMD patients and normal subjects as well. The gene discussed is C5AR1; the disease is age-related macular degeneration.